Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00061867 · ClinicalTrials.gov registry record · Phase 1
Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer
A Phase 1 study, sponsored by Imunon.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00061867 is a Phase 1 study that has completed, run by Imunon.
The verdict
NCT00061867, a Phase 1 study, has completed, sponsored by Imunon.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy, such as liposomal doxorubicin, use different ways to stop tumor cells from dividing so they stop growing or die. Microwave thermotherapy kills tumor cells by heating them to several degrees above body temperature. Combining liposomal doxorubicin with microwave thermotherapy may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of liposomal doxorubicin when given together with microwave thermotherapy in treating patients with prostate cancer.
Interventions
- DRUG pegylated liposomal doxorubicin hydrochloride
- PROCEDURE hyperthermia treatment
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-03 |
| Est. Completion | 2005-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00061867
The ClinicalTrials.gov registry entry for NCT00061867 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Imunon, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which pegylated liposomal doxorubicin hydrochloride is the first listed.
NCT00061867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00061867 about?
NCT00061867 is a clinical study titled "Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer". RATIONALE: Drugs used in chemotherapy, such as liposomal doxorubicin, use different ways to stop tumor cells from dividing so they stop growing or die. Microwave thermotherapy kills tumor cells by heating them to several degrees above body temperature. Combining liposomal doxorubicin with microwave ...
What is the current status of trial NCT00061867?
This trial is currently completed. It is a Phase 1 study. The study started on 2003-03. Estimated completion is 2005-08.
What interventions are being tested in trial NCT00061867?
The interventions under investigation include: pegylated liposomal doxorubicin hydrochloride (DRUG), hyperthermia treatment (PROCEDURE).
Who is sponsoring clinical trial NCT00061867?
This trial is sponsored by Imunon, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.